Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Oseltamivir inhibits H7 influenza virus replication in mice inoculated by the ocular route.

Belser JA, Sleeman K, Pearce MB, Katz JM, Gubareva LV, Tumpey TM.

Antimicrob Agents Chemother. 2012 Mar;56(3):1616-8. doi: 10.1128/AAC.06101-11. Epub 2011 Dec 12.

2.

Ocular infection of mice with influenza A (H7) viruses: a site of primary replication and spread to the respiratory tract.

Belser JA, Wadford DA, Xu J, Katz JM, Tumpey TM.

J Virol. 2009 Jul;83(14):7075-84. doi: 10.1128/JVI.00535-09. Epub 2009 May 20.

3.

Molecular mechanisms underlying oseltamivir resistance mediated by an I117V substitution in the neuraminidase of subtype H5N1 avian influenza A viruses.

Takano R, Kiso M, Igarashi M, Le QM, Sekijima M, Ito K, Takada A, Kawaoka Y.

J Infect Dis. 2013 Jan 1;207(1):89-97. doi: 10.1093/infdis/jis633. Epub 2012 Oct 10.

4.

Pathogenesis, transmissibility, and ocular tropism of a highly pathogenic avian influenza A (H7N3) virus associated with human conjunctivitis.

Belser JA, Davis CT, Balish A, Edwards LE, Zeng H, Maines TR, Gustin KM, Martínez IL, Fasce R, Cox NJ, Katz JM, Tumpey TM.

J Virol. 2013 May;87(10):5746-54. doi: 10.1128/JVI.00154-13. Epub 2013 Mar 13.

5.
6.

Contribution of H7 haemagglutinin to amantadine resistance and infectivity of influenza virus.

Ilyushina NA, Govorkova EA, Russell CJ, Hoffmann E, Webster RG.

J Gen Virol. 2007 Apr;88(Pt 4):1266-74.

PMID:
17374771
7.

Reduction of Neuraminidase Activity Exacerbates Disease in 2009 Pandemic Influenza Virus-Infected Mice.

Ranadheera C, Hagan MW, Leung A, Collignon B, Cutts T, Theriault S, Embury-Hyatt C, Kobasa D.

J Virol. 2016 Oct 14;90(21):9931-9941. Print 2016 Nov 1.

8.

Kinetics of viral replication and induction of host responses in ferrets differs between ocular and intranasal routes of inoculation.

Belser JA, Maines TR, Gustin KM, Katz JM, Tumpey TM.

Virology. 2013 Apr 10;438(2):56-60. doi: 10.1016/j.virol.2013.01.012. Epub 2013 Feb 13.

9.

Inhibition of influenza virus replication by plant-derived isoquercetin.

Kim Y, Narayanan S, Chang KO.

Antiviral Res. 2010 Nov;88(2):227-35. doi: 10.1016/j.antiviral.2010.08.016. Epub 2010 Sep 6.

PMID:
20826184
10.

H1N1 influenza A virus neuraminidase modulates infectivity in mice.

Ferraris O, Escuret V, Bouscambert M, Casalegno JS, Jacquot F, Raoul H, Caro V, Valette M, Lina B, Ottmann M.

Antiviral Res. 2012 Mar;93(3):374-80. doi: 10.1016/j.antiviral.2012.01.008. Epub 2012 Feb 1.

PMID:
22321413
11.

Pathogenesis of avian influenza (H7) virus infection in mice and ferrets: enhanced virulence of Eurasian H7N7 viruses isolated from humans.

Belser JA, Lu X, Maines TR, Smith C, Li Y, Donis RO, Katz JM, Tumpey TM.

J Virol. 2007 Oct;81(20):11139-47. Epub 2007 Aug 8.

12.

Efficacy of the new neuraminidase inhibitor CS-8958 against H5N1 influenza viruses.

Kiso M, Kubo S, Ozawa M, Le QM, Nidom CA, Yamashita M, Kawaoka Y.

PLoS Pathog. 2010 Feb 26;6(2):e1000786. doi: 10.1371/journal.ppat.1000786.

13.

Oseltamivir inhibits influenza virus replication and transmission following ocular-only aerosol inoculation of ferrets.

Belser JA, Maines TR, Creager HM, Katz JM, Tumpey TM.

Virology. 2015 Oct;484:305-12. doi: 10.1016/j.virol.2015.06.020. Epub 2015 Jul 3.

14.

Synthesis and in vitro study of novel neuraminidase inhibitors against avian influenza virus.

Kongkamnerd J, Cappelletti L, Prandi A, Seneci P, Rungrotmongkol T, Jongaroonngamsang N, Rojsitthisak P, Frecer V, Milani A, Cattoli G, Terregino C, Capua I, Beneduce L, Gallotta A, Pengo P, Fassina G, Miertus S, De-Eknamkul W.

Bioorg Med Chem. 2012 Mar 15;20(6):2152-7. doi: 10.1016/j.bmc.2012.01.026. Epub 2012 Jan 26.

PMID:
22342267
15.

Assessment of Antiviral Properties of Peramivir against H7N9 Avian Influenza Virus in an Experimental Mouse Model.

Farooqui A, Huang L, Wu S, Cai Y, Su M, Lin P, Chen W, Fang X, Zhang L, Liu Y, Zeng T, Paquette SG, Khan A, Kelvin AA, Kelvin DJ.

Antimicrob Agents Chemother. 2015 Dec;59(12):7255-64. doi: 10.1128/AAC.01885-15. Epub 2015 Sep 14.

16.

In vivo influenza virus-inhibitory effects of the cyclopentane neuraminidase inhibitor RJW-270201.

Sidwell RW, Smee DF, Huffman JH, Barnard DL, Bailey KW, Morrey JD, Babu YS.

Antimicrob Agents Chemother. 2001 Mar;45(3):749-57.

17.

Amino acid changes in hemagglutinin contribute to the replication of oseltamivir-resistant H1N1 influenza viruses.

Ginting TE, Shinya K, Kyan Y, Makino A, Matsumoto N, Kaneda S, Kawaoka Y.

J Virol. 2012 Jan;86(1):121-7. doi: 10.1128/JVI.06085-11. Epub 2011 Oct 19.

18.

Replication inhibition activity of carbocycles related to oseltamivir on influenza A virus in vitro.

Niikura M, Bance N, Mohan S, Mario Pinto B.

Antiviral Res. 2011 Jun;90(3):160-3. doi: 10.1016/j.antiviral.2011.03.180. Epub 2011 Apr 2.

PMID:
21443905
19.

Amantadine-oseltamivir combination therapy for H5N1 influenza virus infection in mice.

Ilyushina NA, Hoffmann E, Salomon R, Webster RG, Govorkova EA.

Antivir Ther. 2007;12(3):363-70.

PMID:
17591026
20.

Zanamivir-resistant influenza viruses with a novel neuraminidase mutation.

Hurt AC, Holien JK, Parker M, Kelso A, Barr IG.

J Virol. 2009 Oct;83(20):10366-73. doi: 10.1128/JVI.01200-09. Epub 2009 Jul 29.

Supplemental Content

Support Center